Unveiling the Power of BriaCell: Positive Overall Survival Data for All Patient Subtypes in Metastatic Breast Cancer to be Showcased at 2024 SABCS
BriaCell Therapeutics Corp. to Highlight Positive Data at SABCS 2024 Overview PHILADELPHIA and VANCOUVER, British Columbia, Nov. 26, 2024 – BriaCell Therapeutics Corp. announced that it will be showcasing its encouraging overall survival and clinical benefit data from metastatic breast cancer patients, including those with CNS metastasis, at the 2024 San Antonio Breast Cancer Symposium®….